Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, the Board of Directors of the at their meeting held on today i.e., Thursday, May 29, 2025 at the Registered Office of the Company inter-alia has, considered and approved Standalone Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2025, along with Statement of Profit & Loss, Statement of Assets & Liabilities and the Statement of Cash Flow, for the financial year ended March 31, 2025, in accordance with the provisions of Regulation 33 of the SEBI Listing Regulations, along with the Auditors' Reports thereon.

pdf

Natural Biocon (India) Ltd.

23 May 2025

12.42

-5.41%

Company Update

Natural Biocon (India) Ltd - 543207 - Board Meeting Intimation for Meeting Of Board Of Directors …

BSE India

Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve audited Financial Results for the year ended March 31, 2025

pdf

Natural Biocon (India) Ltd.

17 May 2025

12.42

-5.41%

Board Meeting

Natural Biocon (India) Ltd - 543207 - Board Meeting Intimation for Meeting Of The Board Of …

BSE India

Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on 31st March, 2025 along with the Auditor''s Report and Certificate for unmodified opinion Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015;

pdf